{"data":[{"accessionNo":"0001950047-26-010170","issuerCik":"0001434647","issuerName":"Zevra Therapeutics, Inc.","ticker":"ZVRA","personName":"NEIL F MCFARLANE","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":20000,"aggregateMarketValue":227800,"unitsOutstanding":59383781,"approxSaleDate":"2026-10-12","exchange":"NASDAQ","filedAt":"2026-10-13","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0001950047-26-008134","issuerCik":"0001434647","issuerName":"ZEVRA THERAPEUTICS INC","ticker":"ZVRA","personName":"RAHSAAN THOMPSON","relationship":"Officer, Secretary","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":42666,"aggregateMarketValue":477005.88,"unitsOutstanding":59383781,"approxSaleDate":"2026-08-14","exchange":"NASDAQ","filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0001950047-26-006950","issuerCik":"0001434647","issuerName":"ZEVRA THERAPEUTICS, INC.","ticker":"ZVRA","personName":"JOHN BODE","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":10516,"aggregateMarketValue":156162.6,"unitsOutstanding":59115084,"approxSaleDate":"2026-07-08","exchange":"NASDAQ","filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0001950047-26-004326","issuerCik":"0001434647","issuerName":"Zevra Therapeutics, Inc.","ticker":"ZVRA","personName":"Rahsaan Thompson","relationship":"Officer, Chief Legal & Compliance / Secretary","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":36351,"aggregateMarketValue":404586.63,"unitsOutstanding":59115084,"approxSaleDate":"2026-05-11","exchange":"NASDAQ","filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0001950047-26-002681","issuerCik":"0001434647","issuerName":"ZEVRA THERAPEUTICS, INC.","ticker":"ZVRA","personName":"RAYMOND L CLIFTON","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":345428,"aggregateMarketValue":3409374.36,"unitsOutstanding":58711584,"approxSaleDate":"2026-03-16","exchange":"NASDAQ","filedAt":"2026-03-16","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0001950047-26-000828","issuerCik":"0001434647","issuerName":"ZEVRA THERAPEUTICS INC","ticker":"ZVRA","personName":"NEIL F MCFARLANE","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":105625,"aggregateMarketValue":950625,"unitsOutstanding":56297535,"approxSaleDate":"2026-02-02","exchange":"NASDAQ","filedAt":"2026-02-02","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0001950047-26-000771","issuerCik":"0001434647","issuerName":"ZEVRA THERAPEUTICS INC","ticker":"ZVRA","personName":"RAHSAAN THOMPSON","relationship":"Officer, Secretary","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":4080,"aggregateMarketValue":36148.8,"unitsOutstanding":56297535,"approxSaleDate":"2026-01-30","exchange":"NASDAQ","filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0001950047-26-000770","issuerCik":"0001434647","issuerName":"ZEVRA THERAPEUTICS INC","ticker":"ZVRA","personName":"JOSHUA SCHAFER","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":13875,"aggregateMarketValue":122932.5,"unitsOutstanding":56297535,"approxSaleDate":"2026-01-30","exchange":"NASDAQ","filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0001950047-26-000775","issuerCik":"0001434647","issuerName":"ZEVRA THERAPEUTICS INC","ticker":"ZVRA","personName":"TIMOTHY SANGIOVANNI","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":4750,"aggregateMarketValue":42085,"unitsOutstanding":56297535,"approxSaleDate":"2026-01-30","exchange":"NASDAQ","filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0001950047-26-000769","issuerCik":"0001434647","issuerName":"ZEVRA THERAPEUTICS INC","ticker":"ZVRA","personName":"ADRIAN QUARTEL","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":4533,"aggregateMarketValue":40162.38,"unitsOutstanding":56297535,"approxSaleDate":"2026-01-30","exchange":"NASDAQ","filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0001950047-26-000773","issuerCik":"0001434647","issuerName":"ZEVRA THERAPEUTICS INC","ticker":"ZVRA","personName":"R LaDuane Clifton","relationship":"Former CFO & Treasurer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":14000,"aggregateMarketValue":124040,"unitsOutstanding":56297535,"approxSaleDate":"2026-01-30","exchange":"NASDAQ","filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0001950047-25-007899","issuerCik":"0001434647","issuerName":"ZEVRA THERAPEUTICS INC","ticker":"ZVRA","personName":"NEIL F MCFARLANE","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":19500,"aggregateMarketValue":210990,"unitsOutstanding":56135091,"approxSaleDate":"2025-10-10","exchange":"NASDAQ","filedAt":"2025-10-10","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"}],"updatedAt":"2026-11-04T00:28:33.491Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/zvra","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}